RAPT Therapeutics Inc. (RAPT)
NASDAQ: RAPT
· Real-Time Price · USD
11.79
0.54 (4.80%)
At close: Aug 15, 2025, 3:59 PM
11.65
-1.18%
After-hours: Aug 15, 2025, 06:13 PM EDT
RAPT Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | 5.29M | n/a | n/a | n/a | 641K | n/a | 886K | 641K | 756K | 966K | 869K | 1.22M |
Cost of Revenue | 200K | n/a | n/a | n/a | 305K | 314K | 323K | 908K | 853K | 883K | 730K | 728K | 700K | 689K | 231K | n/a | n/a | n/a |
Gross Profit | -200K | n/a | n/a | n/a | -305K | -314K | 4.96M | -908K | -853K | -883K | -89K | -728K | 186K | -48K | 525K | 966K | 869K | 1.22M |
Operating Income | -19.54M | -19.27M | -54.47M | -19.79M | -29.33M | -32.52M | -33.22M | -33.92M | -28.36M | -31.56M | -24.43M | -21.68M | -18.91M | -20.78M | -18.03M | -18.53M | -16.08M | -16.56M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -17.64M | -17.16M | -53.25M | -18.43M | -27.66M | -30.52M | -30.88M | -31.37M | -25.28M | -29.27M | -22.95M | -21.23M | -19.18M | -20.47M | -17.93M | -18.65M | -16.11M | -16.51M |
Net Income | -17.64M | -17.16M | -53.25M | -18.43M | -27.66M | -30.52M | -30.88M | -31.37M | -25.28M | -26.98M | -21.47M | -20.79M | -19.46M | -20.16M | -17.93M | -18.65M | -16.11M | -16.51M |
Selling & General & Admin | 7M | 7.22M | 8.01M | 6.45M | 6.69M | 7.42M | 6.13M | 6.9M | 6.72M | 5.99M | 4.98M | 5.08M | 5.44M | 4.75M | 4.49M | 3.77M | 3.76M | 4.01M |
Research & Development | 12.34M | 12.04M | 46.46M | 13.34M | 22.64M | 24.78M | 26.76M | 27.02M | 21.64M | 25.57M | 19.45M | 16.6M | 14.36M | 16.67M | 14.3M | 15.72M | 13.19M | 13.77M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.55M | 3.08M | 2.29M | 1.48M | 443K | -275K | 309K | 105K | -118K | -29K | 47K |
Operating Expenses | 19.34M | 19.27M | 54.47M | 19.79M | 29.33M | 32.2M | 32.89M | 33.92M | 28.36M | 31.56M | 24.43M | 21.68M | 19.8M | 21.42M | 18.79M | 19.5M | 16.95M | 17.78M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | 2.29M | n/a | n/a | n/a | n/a | n/a | 275K | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | -314K | -323K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 19.54M | 19.27M | 55.4M | 19.79M | 29.33M | 32.52M | 33.22M | 33.92M | 28.36M | 31.56M | 24.43M | 21.68M | 19.8M | 21.42M | 18.79M | 19.5M | 16.95M | 17.78M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | 270.72K | n/a | n/a | n/a | -2.29M | -1.48M | -443K | 275K | -309K | n/a | 29K | 56K | n/a |
Shares Outstanding (Basic) | 26.95M | 215.41M | 46.69M | 38.9M | 38.87M | 38.63M | 38.38M | 38.36M | 38.33M | 38.28M | 35.69M | 33.68M | 31.14M | 29.57M | 29.41M | 29.49M | 25.57M | 24.84M |
Shares Outstanding (Diluted) | 26.95M | 215.41M | 46.69M | 38.9M | 38.87M | 38.63M | 38.38M | 38.36M | 38.33M | 38.28M | 35.69M | 33.68M | 31.14M | 29.57M | 29.54M | 29.49M | 25.59M | 24.84M |
EPS (Basic) | -0.65 | -0.08 | -1.14 | -0.47 | -0.71 | -0.79 | -0.8 | -0.82 | -0.66 | -0.7 | -0.6 | -0.62 | -0.62 | -0.68 | -0.61 | -0.63 | -0.63 | -0.66 |
EPS (Diluted) | -0.65 | -0.08 | -1.14 | -0.47 | -0.71 | -0.79 | -0.8 | -0.82 | -0.66 | -0.7 | -0.6 | -0.62 | -0.62 | -0.68 | -0.61 | -0.63 | -0.63 | -0.66 |
EBITDA | -17.44M | -19.01M | -54.18M | -19.49M | -29.02M | -32.2M | -32.89M | -33.59M | -28.09M | -31.26M | -24.22M | -21.42M | -18.64M | -20.52M | -17.8M | -18.3M | -15.82M | -16.28M |
EBIT | -17.64M | -19.27M | -54.47M | -19.79M | -29.33M | -32.52M | -33.22M | -33.92M | -28.36M | -31.56M | -24.43M | -21.68M | -18.91M | -20.78M | -18.03M | -18.53M | -16.08M | -16.56M |
Depreciation & Amortization | 200K | 252K | 287K | 297K | 305K | 314K | 323K | 908K | 853K | 883K | 730K | 728K | 700K | 689K | 231K | 200K | 200K | 280K |